Studies investigating the role of LGR5 in early colorectal adenomas found that LGR5-KD reduced the survival of epidermal growth factor (EGF)-treated cancer cells, induced proliferation, and enhanced cell cycle progression [91]. This evidence concerns the gene LGR5 and cancer.